• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    Alphatec Holdings Launches IdentiTI PO Interbody Implant System

    Jocelyn Aspa
    Sep. 25, 2019 08:38AM PST
    Medical Device Investing

    The launch comes after successful alpha evaluations that started in January and makes the fifth of six systems to be launched in 2019.

    Alphatec Holdings (NASDAQ:ATEC) has announced it has commercially launched its IdentiTI TLIF Posterior Oblique Titanium Interbody Implant System.

    As quoted in the press release:

    The launch of IdentiTi (TLIF) PO follows successful alpha evaluations that began in January 2019 and marks the fifth of six IdentiTi Implant Systems to be launched this year by ATEC’s Organic Innovation Machine™.

    “We continue to execute exceptionally well in our pursuit of increased market share through clinical distinction,” said Pat Miles, Chairman and Chief Executive Officer. “ATEC’s line of IdentiTi Implant Systems brings modernized technology to our portfolio that improves outcomes and elevates the sophistication of spine fusion.  The latest addition of IdentiTi (TLIF) PO provides that same sophistication to those preferring to place oblique implants during a TLIF approach.  It is incredibly exciting to see the investments we’ve made into innovation reach fruition and begin to accelerate growth organically.”

    IdentiTi TLIF Posterior Oblique Porous Titanium Interbody Implant System

    With a self-distracting bulleted nose, smooth medial-lateral surfaces, and rounded edges, IdentiTi PO has been thoughtfully engineered to improve implant insertion while protecting soft tissue and nerve roots. IdentiTi PO implants are also uniquely designed with anti-migration teeth and lordosis in the oblique plane to optimize surgical outcomes.

    Click here to read the full press release.

    alphatec holdingsmedical device investingnasdaq:atec
    The Conversation (0)

    Go Deeper

    AI Powered
    Row of test tubes and pipette with chemical droplet chemical coming from it.

    Top 5 Small-cap Biotech Stocks of 2025

    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cardiex Limited

    CDX:AU
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    Ă—